Bimzelx 320 mg, solution injectable en seringue préremplie

7680685480033 CH-68548 Lösung

Associated product:

BIMZELX sol inj 320 mg/2ml ser pré 1 pce

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
25/02/2026
Summary of Product Characteristics
Français
25/02/2026
Summary of Product Characteristics
Italien
25/02/2026

Detailed composition

Substance Quantity Type Category
bimekizumabum
320.0 MG Substance Wirkstoff (Principe actif)
glycinum
- Substance HNIDK
natrii acetas trihydricus
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.9 MG Substance HBESI

Reimbursement information

Public price
CHF 2008.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2026

Authorization holder

UCB-Pharma SA

1630 Bulle

Authorization information

Swissmedic authorization number
68548
Drug name
Bimzelx, solution injectable en seringue préremplie
Galenic form
INLFS
ATC Code
L04AC21
Authorization status
Z
Dispensing category
B
First authorization
27/10/2022
Authorization expiration date
26/10/2027
IT Number
07.15.0.
Domain
Human medicine

Package details

Description (FR)
BIMZELX sol inj 320 mg/2ml ser pré 1 pce
Description (DE)
BIMZELX Inj Lös 320 mg/2ml Fertspr 1 Stk
Market launch
01/06/2026
Narcotic (BTM)
No

Other package sizes (2)

BIMZELX 160 mg/ml ser pré (emb individ) 1 ml
1 FESP
GTIN: 7680685480019
View
BIMZELX 160 mg/ml ser pré (emb double) 2 x 1 ml
2 FESP
GTIN: 7680685480026
View
Buy us a coffee Explore the data